Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126733
Filing Date
2024-11-14
Accepted
2024-11-14 07:14:02
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20240930.htm   iXBRL 10-Q 2413109
2 EX-10.1 caba-ex10_1.htm EX-10.1 221988
3 EX-10.2 caba-ex10_2.htm EX-10.2 29422
4 EX-10.3 caba-ex10_3.htm EX-10.3 71914
5 EX-10.4 caba-ex10_4.htm EX-10.4 40107
6 EX-31.1 caba-ex31_1.htm EX-31.1 17103
7 EX-31.2 caba-ex31_2.htm EX-31.2 17080
8 EX-32.1 caba-ex32_1.htm EX-32.1 9635
9 EX-32.2 caba-ex32_2.htm EX-32.2 10145
10 GRAPHIC img214354919_0.jpg GRAPHIC 8005
11 GRAPHIC img216201961_0.jpg GRAPHIC 9364
12 GRAPHIC img216201961_1.jpg GRAPHIC 9364
  Complete submission text file 0000950170-24-126733.txt   8410896

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20240930.xsd EX-101.SCH 899856
66 EXTRACTED XBRL INSTANCE DOCUMENT caba-20240930_htm.xml XML 1344849
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 241457155
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)